Toggle light / dark theme

Performance characteristics of genome-sequencing–based CHIP calling and impact on epidemiologic associations

Do we need better ways to detect clonal hematopoiesis of indeterminate potential (CHIP)?

In this Research Letter, Alexander G. Bick & team find epidemiology studies underestimate the strength of the association between clonal hematopoiesis and disease due to false negatives from shallow, whole-genome versus deep targeted sequencing.


Address correspondence to: Alexander Bick, 2,200 Pierce Ave., 550 RRB, Nashville, Tennessee, 37,232, USA. Email: [email protected].

Find articles by Corty, R. in: | Google Scholar

1Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */